163
Participants
Start Date
July 4, 2023
Primary Completion Date
December 22, 2024
Study Completion Date
August 29, 2025
Clinical tests
The investigators perform the following clinical tests: vibration threshold test, monofilament test, and height, weight and waist circumference measurement in every participant.
Biochemical tests
The investigators perform blood and urine tests in every participant.
DXA scan with TBS and VFA
The investigators perform a dual energy x-ray absorptiometry (DXA scan or osteodensitometry) including trabecular bone score (TBS) and Vertebral Fracture Assessment (VFA) in every participant.
AGEReader
The investigators perform a skin advanced glycation end products (AGEs) measurement with the AGE Reader machine in every participant.
Institut de recherches cliniques de Montréal (IRCM), Montreal
Centre de recherche du CHU de Québec-Université Laval, Québec
Diabetes Canada
OTHER
CHU de Quebec-Universite Laval
OTHER